CBBT Gross Margin

The Gross Margin of Cerebain Biotech Corp (CBBT) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CBBT Gross Margin - Peers Comparison

Ticker	Name	Value
IMMB	Immunotech Laboratories Inc	7775.20%
KNE.V	Kane Biotech Inc	73.48%
NSTM	Novelstem International Corp	13.90%
PPCB	Propanc Biopharma Inc	7775.20%
BIEI	Premier Graphene Inc	9.94%
NOHO	Novation Holdings Inc	76.90%
VXL.V	Vaxil Bio Ltd	7775.20%
XSNX	NovAccess Global Inc	34.03%
AMBS	Amarantus Bioscience Holdings Inc	7775.20%
MBI.H.V	Many Bright Ideas Technologies Inc	7775.20%
WAVE.V	Waverley Pharma Inc	19.36%
BZYR	Burzynski Research Institute Inc	7775.20%
ANTH	Anthera Pharmaceuticals Inc	7775.20%
PFND	Pathfinder Cell Therapy Inc	31.48%
OVIT	Oncovista Innovative Therapies Inc	7775.20%
MRPI	Mera Pharmaceuticals Inc	94.63%
PAS.V	Pascal Biosciences Inc	7775.20%
TLOG	TetraLogic Pharmaceuticals Corp	7775.20%
APC.V	Advanced Proteome Therapeutics Corporation	39.66%
IMUC	Eom Pharmaceutical Holdings Inc	7775.20%
OBMP	Theralink Technologies Inc	70.98%
TXTM	Protext Mobility Inc	100.00%
VGLS	VG Life Sciences Inc	7775.20%
CAPS	Capstone Holding Corp	84.75%